Innovation Pharmaceuticals Inc (IPIX)

[frenchbroad]

Q2 2024 is over and the middle of 2024 is here.

This is super correct.
Three months for last USA FDA approval on the BeaMed system: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K232769
BeaMed has distributors and will be ready to sell with approval day. They maybe allready sell some system contingent for approval.
For sales in USA they have ForTec:
"BeaMed has in place a U.S. distribution partnership with ForTec Medical, a mobilizer of surgical laser technology with access to over 2,200 hospitals in the U.S. This means BeaMed is in the enviable position for an immediate market launch upon FDA clearance, which we are optimistic is attainable in 2024."
https://www.ipharminc.com/press-release/2023/2/23/innovation-pharmaceuticals-visits-beamed-new-stingray-laser-system-for-epilepsy-and-brain-tumors-moving-toward-fda-submission
For other sales they have Shina:
“This agreement provides us with two key strategic advantages,” said Gil Shapira, Chief Executive Officer of BeaMed. “The first is immediate access to decades of experience and knowledge regarding design and implementation of high end medical imaging platforms including MRI access, 3D image processing and visualization, and superlative usability. The second is acceleration of our development timeline to get through FDA clearance and market launch quickly. This path underscores the execution-focused strategy of BeaMed to successfully bring its innovation to the market efficiently and expeditiously.”
https://www.ipharminc.com/press-release/2023/1/9/innovation-pharmaceuticals-announces-bt-beamedical-technologies-and-shina-systems-ltd-enter-into-a-definitive-strategic-development-agreement

I expect a Ipix wake up and filing and re-trading before November.
While Ipix sleeps the Brilacidin research and potential value goes on and on. It is a remarkable new drug.